ENGAGEMENT SURVEY II

Quote




Anonymous said:
IF THE J&J ENGAGEMENT SURVEY RESULTS ARE NOT SHARED WITH FIELD RBDs & DM THEN HOW COME OUR DM JUST WENT OVER THE DISTRICT RESULTS WITH US?
Click to expand...

Engagement surveys are a Gallop Co. marketing buy-in program as follows:

The ratings come from 12 questions are then combined into an index, which are used to segment employees into 3 categories:

1) Engaged employees work with passion. Because they feel a strong connection to the organization, they work hard to innovate and improve.

2) Not-Engaged employees do the work expected of them, but do not put in extra effort.

3) Actively Disengaged employees aren’t just unhappy, but are spreading their unhappiness to other staff.
 




Anonymous said:
Engagement surveys are a Gallop Co. marketing buy-in program as follows:

The ratings come from 12 questions are then combined into an index, which are used to segment employees into 3 categories:

1) Engaged employees work with passion. Because they feel a strong connection to the organization, they work hard to innovate and improve.

2) Not-Engaged employees do the work expected of them, but do not put in extra effort.

3) Actively Disengaged employees aren’t just unhappy, but are spreading their unhappiness to other staff.
Click to expand...

I am a 1.5 -- with a bit of 3 -- every now & then. Like when I got Q2 Nuc goals.
 




Anonymous said:
I am a 1.5 -- with a bit of 3 -- every now & then. Like when I got Q2 Nuc goals.
Click to expand...

The company is, as usual, creating more 3's every day they delay announcing what the Post-June-30th situation will be.

Reminds me of the time spent waiting to see which conference call was which back in April, 2009 (when 1000 people got laid off).
 








Anonymous said:
This is a reassignment not realignment.
Click to expand...

Maybe it is a reassignment, but there will be territory changes, manager changes, district line changes, regional line changes, etc. There will be many, many changes. Some will be positive, some perhaps not so good. With only about 120 new positions, but 2-4 reps per footprint, territories are sure to get much larger for some people. If there are no lay-offs, why can't they just tell us where our new territories are located and who our manager is?
 




Anonymous said:
Maybe it is a reassignment, but there will be territory changes, manager changes, district line changes, regional line changes, etc. There will be many, many changes. Some will be positive, some perhaps not so good. With only about 120 new positions, but 2-4 reps per footprint, territories are sure to get much larger for some people. If there are no lay-offs, why can't they just tell us where our new territories are located and who our manager is?
Click to expand...

Next week you will know all.
 












Re: ENGAGEMENT SURVEY II - J&J

J&J to Host Pharmaceuticals Business Review on Thurs., May 26th
http://www.investor.jnj.com/releaseDetail.cfm?ReleaseID=579470

NEW BRUNSWICK, N.J., -- JNJ will host a review of its Pharmaceuticals business beginning at 9:00 a.m. (ET) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J.

Sheri McCoy, Vice Chairman, Executive Committee, & Pharmaceuticals Worldwide Chairmen Joaquin Duato and Paul Stoffels, M.D. will discuss the role the segment plays in the Company's overall business and growth strategy. The meeting will feature presentations from the 5 therapeutic area leaders in the Pharmaceuticals research and development organization.

A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.
 




Re: ENGAGEMENT SURVEY II - J&J

Anonymous said:
J&J to Host Pharmaceuticals Business Review on Thurs., May 26th
http://www.investor.jnj.com/releaseDetail.cfm?ReleaseID=579470

NEW BRUNSWICK, N.J., -- JNJ will host a review of its Pharmaceuticals business beginning at 9:00 a.m. (ET) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J.

Sheri McCoy, Vice Chairman, Executive Committee, & Pharmaceuticals Worldwide Chairmen Joaquin Duato and Paul Stoffels, M.D. will discuss the role the segment plays in the Company's overall business and growth strategy. The meeting will feature presentations from the 5 therapeutic area leaders in the Pharmaceuticals research and development organization.

A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.
Click to expand...

This is the same "Sheri McCoy" who told Business Week mag that the future was non-personal calls on primary care physicians, AKA e-detailing. Funny, to this day she has not retracted those statements, but instead the salesforce is fed an endless stream of PR.
 




Re: ENGAGEMENT SURVEY II - J&J

Anonymous said:
This is the same "Sheri McCoy" who told Business Week mag that the future was non-personal calls on primary care physicians, AKA e-detailing. Funny, to this day she has not retracted those statements, but instead the salesforce is fed an endless stream of PR.
Click to expand...

AMEN BRO!!!!!!!
 




























Top Bottom
Back
Quote